{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T09:44:32Z","timestamp":1751449472550,"version":"3.41.0"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,6,1]]},"DOI":"10.2169\/internalmedicine.5053-24","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T22:14:59Z","timestamp":1742595299000},"page":"1691-1695","source":"Crossref","is-referenced-by-count":2,"title":["New-onset Fulminant Type 1 Diabetes Following COVID-19 Vaccination"],"prefix":"10.2169","volume":"64","author":[{"given":"Takaaki","family":"Shigematsu","sequence":"first","affiliation":[{"name":"Fraternity Memorial Hospital, Department of Diabetology and Metabolism, Japan"},{"name":"Tokyo Metropolitan Tama Medical Center, Department of Endocrinology and Metabolism, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Fraternity Memorial Hospital, Department of Diabetology and Metabolism, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Fraternity Memorial Hospital, Department of Diabetology and Metabolism, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Sato","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Tama Medical Center, Department of Endocrinology and Metabolism, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyoshi","family":"Tsujino","sequence":"additional","affiliation":[{"name":"Tokyo Metropolitan Tama Medical Center, Department of Endocrinology and Metabolism, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. \u015eendur SN, O\u011fuz SH, \u00dcnl\u00fct\u00fcrk U. COVID-19 vaccination and thyroiditis. Best Pract Res Clin Endoc Metab 37: 101759, 2023.","DOI":"10.1016\/j.beem.2023.101759"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Abolmaali M, Rezania F, Behnagh AK, Hamidabad NM, Gorji A, Mirzaasgari Z. Guillain-Barr\u00e9 syndrome in association with COVID-19 vaccination: a systematic review. Immunol Res 70: 752-764, 2022.","DOI":"10.1007\/s12026-022-09316-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Vuille-Lessard \u00c9, Montani M, Bosch J, Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun 123: 102710, 2021.","DOI":"10.1016\/j.jaut.2021.102710"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sakurai K, Narita D, Saito N, et al. Type 1 diabetes mellitus following COVID-19 RNA-based vaccine. J Diabetes Investig 13: 1290-1292, 2022.","DOI":"10.1111\/jdi.13781"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sasaki H, Itoh A, Watanabe Y, et al. Newly developed type 1 diabetes after coronavirus disease 2019 vaccination. J Diabetes Investig 13: 1105-1108, 2022.","DOI":"10.1111\/jdi.13757"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yano M, Morioka T, Natsuki Y, et al. New-onset type 1 diabetes after COVID-19 mRNA vaccination. Intern Med 61: 1197-1200, 2022.","DOI":"10.2169\/internalmedicine.9004-21"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Aydo\u011fan BI, \u00dcnl\u00fct\u00fcrk U, Cesur M. Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination. Endocrine 78: 42-46, 2022.","DOI":"10.1007\/s12020-022-03130-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kobayashi T, Yakou F, Saburi M, et al. New-onset atypical fulminant type 1 diabetes after COVID-19 vaccination. Clin Case Rep 10: e6473, 2022.","DOI":"10.1002\/ccr3.6473"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lin R, Lin YW, Chen MH. Fulminant type 1 diabetes mellitus after SARS-CoV-2 vaccination. Vaccines 10: 1905, 2022.","DOI":"10.3390\/vaccines10111905"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sasaki K, Morioka T, Okada N, et al. New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination. J Diabetes Investig 13: 1286-1289, 2022.","DOI":"10.1111\/jdi.13771"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Izumi T, Takahashi H, Takahashi H. Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination. Diabetol Int 14: 422-426, 2023.","DOI":"10.1007\/s13340-023-00648-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med 342: 1835-1837, 2000.","DOI":"10.1056\/NEJM200006153422413"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hanafusa T, Imagawa A. Insulitis in human type 1 diabetes. Ann N Y Acad Sci 1150: 297-299, 2008.","DOI":"10.1196\/annals.1447.052"},{"key":"14","unstructured":"14. Ishizuka N, Fujimoto S, Matsuoka K, Fukuda K, Muraguchi N, Inagaki N. A case of fulminant type 1 diabetes mellitus developed after pancreatic swelling. Tonyobyo (J Jpn Diabetes Soc) 50: 853-858, 2007 (in Japanese, Abstract in English)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ochi A, Kawaguchi Y, Sakuma N, et al. Fluminant type 1 diabetes mellitus whose pancreas followed morphologically by computed tomography from the pre-onset phase. J Jpn Soc Intern Med 98: 2592-2594, 2009 (in Japanese).","DOI":"10.2169\/naika.98.2592"},{"key":"16","unstructured":"16. Kamiyama H, Shigematsu E, Inoue Y, Nezu U, Yamakawa T, Terauchi Y. A case of fulminant type 1 diabetes mellitus complicated by severe acute pancreatitis. Tonyobyo (J Jpn Diabetes Soc) 55: 456-462, 2012 (in Japanese, Abstract in English)."},{"key":"17","unstructured":"17. Nakajima S, Takahashi T, Tanaka Y, et al. A case of fulminant type 1 diabetes following acute pancreatitis during early pregnancy. Tonyobyo (J Jpn Diabetes Soc) 55: 987-992, 2012 (in Japanese, Abstract in English)."},{"key":"18","unstructured":"18. Santo T, Ihara Y, Yano H. A case of fulminant type 1 diabetes-like disease accompanied by diffuse erythema and significant pancreatic enlargement just before the onset of the disease. Tonyobyo (J Jpn Diabetes Soc) 58: 419-425, 2015 (in Japanese, Abstract in English)."},{"key":"19","unstructured":"19. Miyagahara T, Fujimori N, Oono T, et al. Fulminant type 1 diabetes mellitus following acute pancreatitis and hypoglycemia with sequential imaging of the pancreas using computed tomography. Nihon Shokakibyo Gakkai Zasshi (J Jpn Soc Gastroenterol) 116: 161-167, 2019 (in Japanese, Abstract in English)."},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Kawabata Y, Ikegami H, Awata T, et al.; the Committee on Type 1 Diabetes, Japan Diabetes Society. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 52: 2513-2521, 2009.","DOI":"10.1007\/s00125-009-1539-9"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tsutsumi C, Imagawa A, Ikegami H, Makino H, Kobayashi T, Hanafusa T. Class II HLA genotype in fulminant type 1 diabetes: a nationwide survey with reference to glutamic acid decarboxylase antibodies. Diabetes Investig 3: 62-69, 2012.","DOI":"10.1111\/j.2040-1124.2011.00139.x"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_5053-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T04:39:34Z","timestamp":1749271174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/11\/64_5053-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5053-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"5053-24"}}